Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples

Detalhes bibliográficos
Autor(a) principal: Safren, Steven A.
Data de Publicação: 2015
Outros Autores: Mayer, Kenneth H., Ou, San-San, McCauley, Marybeth, Grinsztejn, Beatriz, Hosseinipour, Mina C., Kumarasamy, Nagalingeswaran, Gamble, Theresa, Hoffman, Irving, Celentano, David, Chen, Ying Qing, Cohen, Myron S., HPTN 052 Study Team
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/29534
Resumo: Massachusetts General Hospital. Department of Psychiatry. Boston, MA, USA./ Harvard Medical School. Boston, MA, USA./ Fenway Health. Boston, MA, USA.
id CRUZ_bae7f126ca5987c283c9ba1982540bcf
oai_identifier_str oai:www.arca.fiocruz.br:icict/29534
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Safren, Steven A.Mayer, Kenneth H.Ou, San-SanMcCauley, MarybethGrinsztejn, BeatrizHosseinipour, Mina C.Kumarasamy, NagalingeswaranGamble, TheresaHoffman, IrvingCelentano, DavidChen, Ying QingCohen, Myron S.HPTN 052 Study Team2018-10-11T16:03:05Z2018-10-11T16:03:05Z2015SAFREN, Steven A. et al. Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples. Journal of acquired immune deficiency syndromes, v. 69, n. 2, p. 234–240, 20151525-4135https://www.arca.fiocruz.br/handle/icict/2953410.1097/QAI.0000000000000593engAdherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couplesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleMassachusetts General Hospital. Department of Psychiatry. Boston, MA, USA./ Harvard Medical School. Boston, MA, USA./ Fenway Health. Boston, MA, USA.Harvard Medical School. Boston, MA, USA./ Fenway Health. Boston, MA, USA./ Beth Israel Deaconess Medical Center. Boston, MA, USA.Fred Hutchinson Cancer Research Center. Prevention, Vaccine and Infectious Disease Division. Statistical Center for HIV/AIDS Research. Seattle, WA, USA.FHI 360. Washington, DC, USA.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.University of North Carolina at Chapel Hill. Institute for Global Health and Infectious Diseases. Lilongwe, Malawi.YRG CARE Medical Ctr. VHS Chennai CRS. Channai, Tamil Nadu, India.FHI 360. Durham, DC, USA.University of North Carolina School of Medicine. Department of Medicine. Division of Infectious Diseases. Chapel Hill, NC, USA.John Hopkins University. Bloomberg School of Public Health. Baltimore, MD, USA.Combination antiretroviral therapy (ART) for HIV-1-infected individuals prevents sexual transmission if viral load is suppressed.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/29534/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALAdherence to early antiretroviral therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdfAdherence to early antiretroviral therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdfapplication/pdf177891https://www.arca.fiocruz.br/bitstream/icict/29534/2/Adherence%20to%20early%20antiretroviral%20therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf2974fe04e47eec9c3cb826d9d26592d8MD52TEXTAdherence to early antiretroviral therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf.txtAdherence to early antiretroviral therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf.txtExtracted texttext/plain39891https://www.arca.fiocruz.br/bitstream/icict/29534/3/Adherence%20to%20early%20antiretroviral%20therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf.txt4d5c5f1dd66f4554e004e77d1bc1ac37MD53icict/295342019-08-20 11:25:13.503oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-08-20T14:25:13Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
title Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
spellingShingle Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
Safren, Steven A.
title_short Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
title_full Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
title_fullStr Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
title_full_unstemmed Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
title_sort Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples
author Safren, Steven A.
author_facet Safren, Steven A.
Mayer, Kenneth H.
Ou, San-San
McCauley, Marybeth
Grinsztejn, Beatriz
Hosseinipour, Mina C.
Kumarasamy, Nagalingeswaran
Gamble, Theresa
Hoffman, Irving
Celentano, David
Chen, Ying Qing
Cohen, Myron S.
HPTN 052 Study Team
author_role author
author2 Mayer, Kenneth H.
Ou, San-San
McCauley, Marybeth
Grinsztejn, Beatriz
Hosseinipour, Mina C.
Kumarasamy, Nagalingeswaran
Gamble, Theresa
Hoffman, Irving
Celentano, David
Chen, Ying Qing
Cohen, Myron S.
HPTN 052 Study Team
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Safren, Steven A.
Mayer, Kenneth H.
Ou, San-San
McCauley, Marybeth
Grinsztejn, Beatriz
Hosseinipour, Mina C.
Kumarasamy, Nagalingeswaran
Gamble, Theresa
Hoffman, Irving
Celentano, David
Chen, Ying Qing
Cohen, Myron S.
HPTN 052 Study Team
description Massachusetts General Hospital. Department of Psychiatry. Boston, MA, USA./ Harvard Medical School. Boston, MA, USA./ Fenway Health. Boston, MA, USA.
publishDate 2015
dc.date.issued.fl_str_mv 2015
dc.date.accessioned.fl_str_mv 2018-10-11T16:03:05Z
dc.date.available.fl_str_mv 2018-10-11T16:03:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv SAFREN, Steven A. et al. Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples. Journal of acquired immune deficiency syndromes, v. 69, n. 2, p. 234–240, 2015
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/29534
dc.identifier.issn.pt_BR.fl_str_mv 1525-4135
dc.identifier.doi.none.fl_str_mv 10.1097/QAI.0000000000000593
identifier_str_mv SAFREN, Steven A. et al. Adherence to early antiretroviral therapy: results from HPTN 052, a phase III, multinational randomized trial of ART to prevent HIV-1 sexual transmission in serodiscordant couples. Journal of acquired immune deficiency syndromes, v. 69, n. 2, p. 234–240, 2015
1525-4135
10.1097/QAI.0000000000000593
url https://www.arca.fiocruz.br/handle/icict/29534
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/29534/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/29534/2/Adherence%20to%20early%20antiretroviral%20therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf
https://www.arca.fiocruz.br/bitstream/icict/29534/3/Adherence%20to%20early%20antiretroviral%20therapy_Beatriz_Grinsztejn_etal_INI_Lapclin-AIDS_2015.pdf.txt
bitstream.checksum.fl_str_mv 586c046dcfeef936e32f0323bb9a47c0
2974fe04e47eec9c3cb826d9d26592d8
4d5c5f1dd66f4554e004e77d1bc1ac37
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009259060789248

Registros relacionados